Jammie Law M.D. is a board-certified rheumatologist and currently Assistant Professor of Medicine in the Division of Rheumatology and Connective Tissue Research. She completed medical school at Albert Einstein College of Medicine with additional research experience in frailty markers in critically ill older adults. She trained in internal medicine at Montefiore Medical Center graduating with special distinction in Medical Education. At Montefiore, she co-built clinical registries of a diverse urban population of patients with inflammatory myositis and cardiovascular complications of systemic lupus erythematosus with subsequent peer reviewed presentations. She continued her rheumatology fellowship training at NYU Grossman School of Medicine with additional research training in lupus clinical trial design, disease assessment tools, and vaccinations in rheumatic patients. She was drawn to rheumatology to empower patients with individualized evidence-based treatment plans and to provide compassionate and collaborative multi-specialty care. She also plays an active role teaching fellows, residents, and medical students at Robert Wood Johnson Hospital. She is bilingual and practices in both English and Cantonese.
Clinical Interests
Healthcare disparities, connective tissue disease especially systemic lupus erythematosus, Sjogren’s Disease, and inflammatory myositis, quality improvement. medical education, reproductive health in rheumatic diseases, and integrative rheumatology
Awards
Special Distinction in Medical Education: Montefiore Medical Center
Departmental Outstanding Achievement in General Biology
College
Stony Brook University
Medical School
Albert Einstein College of Medicine
Residency
Montefiore Medical Center
Fellowship
NYU Grossman School of Medicine - Rheumatology
Publications
Title:
Saxena A, Sorrento C, Izmirly P, Sullivan J, Gamez-Perez M, Law J, Belmont HM, Buyon JP. Low versus high initial oral glucocorticoid dose for lupus nephritis: a pooled analysis of randomised controlled clinical trials. Lupus Sci Med. 2025 Jan 6;12(1).
Authors:
Publisher:
Date:
Issue:
Description:
Title:
Law J, Sorrento C, Saxena A. Vaccination updates and special considerations for systemic lupus erythematosus patients. Curr Opin Rheumatol. 2024 Mar 1;36(2):148-153. Epub 2023 Nov 16. PMID: 37976046.
Authors:
Publisher:
Date:
Issue:
Description:
Title:
Law J, Guerrero MS, Mowrey WB, Horton DB, Briceno D, Broder A. Association of Hydroxychloroquine Dose With Adverse Cardiac Events in Patients With Systemic Lupus Erythematosus. Arthritis Care Res (Hoboken). 2023 Aug;75(8):1673-1680. Epub 2023 Feb 3. PMID:
Authors:
Publisher:
Date:
Issue:
Description:
Title:
Law J, Rackoff P, Tseng CE, Belmont HM, Clancy RM, Buyon JP, Izmirly PM. Breakthrough SARS-CoV-2 infections, morbidity, and seroreactivity following initial COVID-19 vaccination series and additional dose in patients with SLE in New York City. Lancet
Authors:
Publisher:
Date:
Issue:
Description:
Title:
Law J, Nauka PC, Nguyen A, LeFrancois D. Remitting Seronegative Symmetrical Synovitis with Pitting Edema (RS3PE) Associated with DPP-4 Inhibitor. Am J Med. 2021 Jul;134(7):e412-e414. doi: 10.1016/j.amjmed.2021.01.023. Epub 2021 Feb 21. PMID: 33621536.
Authors:
Publisher:
Date:
Issue:
Description:
Title:
Law J, Nair R, Kim M, Verghese J, Gong MN. Frailty, Acute Organ Dysfunction, and Increased Disability After Hospitalization in Older Adults Who Survive Critical Illness: A Prospective Cohort Study. J Intensive Care Med. 2020 Dec;35(12):1505-1512. doi:
Authors:
Publisher:
Date:
Issue:
Description:
Insurance
Accepted Health Plan information is only as accurate as the most current
information submitted. Prior to your appointment, it is advisable to verify
with a physician office that they are still a participating provider.
